Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

15.6%

7 terminated/withdrawn out of 45 trials

Success Rate

77.4%

-9.1% vs industry average

Late-Stage Pipeline

16%

7 trials in Phase 3/4

Results Transparency

54%

13 of 24 completed trials have results

Key Signals

2 recruiting13 with results

Enrollment Performance

Analytics

N/A

23(54.8%)

Phase 2

6(14.3%)

Phase 1

5(11.9%)

Phase 4

5(11.9%)

Phase 3

2(4.8%)

Early Phase 1

1(2.4%)

42Total

N/A(23)

Phase 2(6)

Phase 1(5)

Phase 4(5)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (45)

Showing 20 of 45 trials

NCT05599620Not ApplicableCompleted

Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma

Role: lead

NCT05184556Not ApplicableActive Not Recruiting

Project HOME: Home-Based Treatment Options and Mechanisms for Eating Disorders

Role: collaborator

NCT05839119Phase 1Terminated

Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant

Role: collaborator

NCT03589547Phase 2Completed

Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung

Role: collaborator

NCT06805799Not ApplicableNot Yet Recruiting

Stress Reactivity and Mother-Infant Cardiovascular Disease Risk

Role: lead

NCT06953479Phase 4Recruiting

Implementing Low-Barrier HCV Treatment in a Jail Setting

Role: lead

NCT05512143Not ApplicableActive Not Recruiting

TMS for PTSD and Blood Pressure

Role: lead

NCT05699642Phase 2Active Not Recruiting

Online Tai Chi Plus Fitbit After ACS

Role: collaborator

NCT04626245Not ApplicableActive Not Recruiting

Mindfulness & Mechanisms Study

Role: lead

NCT03850912Not ApplicableCompleted

Symptom Management Implementation of Patient Reported Outcomes in Oncology

Role: collaborator

NCT02353312Not ApplicableCompleted

Rhode Island Diastolic Dysfunction - Heart Failure

Role: collaborator

NCT03789591Phase 3Completed

Hydroxyurea Optimization Through Precision Study

Role: lead

NCT05646446Not ApplicableWithdrawn

Integrated Alcohol and Sexual Assault Prevention for Bisexual Women

Role: lead

NCT06880718Phase 4Not Yet Recruiting

Injectable Buprenorphine in Prison: a Preference Trial

Role: lead

NCT05110313Phase 4Completed

Effects of Tildrakizumab on Epigenetic Age

Role: collaborator

NCT06354465Recruiting

Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews

Role: lead

NCT04598321Phase 1Terminated

BrUOG 390: Neoadjuvant Treatment With Talazoparib

Role: collaborator

NCT03679117Not ApplicableCompleted

Prenatal Mindfulness & Hypertension Study

Role: lead

NCT05773027Not ApplicableCompleted

Integrated Alcohol and Sexual Assault Intervention for College Men

Role: lead

NCT04139213Phase 2Unknown

Medication Maintenance Therapy in Community Pharmacy Settings

Role: lead